358 related articles for article (PubMed ID: 24744763)
21. Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium.
Creyns B; Jacobs I; Verstockt B; Cremer J; Ballet V; Vandecasteele R; Vanuytsel T; Ferrante M; Vermeire S; Van Assche G; Ceuppens JL; Breynaert C
Front Immunol; 2020; 11():1847. PubMed ID: 32983101
[TBL] [Abstract][Full Text] [Related]
22. Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?
Vacca P; Munari E; Tumino N; Moretta F; Pietra G; Vitale M; Del Zotto G; Mariotti FR; Mingari MC; Moretta L
Immunol Lett; 2018 Sep; 201():14-19. PubMed ID: 30439479
[TBL] [Abstract][Full Text] [Related]
23. Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia.
Audia S; Moulinet T; Ciudad-Bonté M; Samson M; Facy O; Ortega-Deballon P; Saas P; Bonnotte B
J Autoimmun; 2018 Sep; 93():139-144. PubMed ID: 30055825
[TBL] [Abstract][Full Text] [Related]
24. NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.
Carrega P; Loiacono F; Di Carlo E; Scaramuccia A; Mora M; Conte R; Benelli R; Spaggiari GM; Cantoni C; Campana S; Bonaccorsi I; Morandi B; Truini M; Mingari MC; Moretta L; Ferlazzo G
Nat Commun; 2015 Sep; 6():8280. PubMed ID: 26395069
[TBL] [Abstract][Full Text] [Related]
25. NK cells and ILCs in tumor immunotherapy.
Sivori S; Pende D; Quatrini L; Pietra G; Della Chiesa M; Vacca P; Tumino N; Moretta F; Mingari MC; Locatelli F; Moretta L
Mol Aspects Med; 2021 Aug; 80():100870. PubMed ID: 32800530
[TBL] [Abstract][Full Text] [Related]
26. Characterization of Rat ILCs Reveals ILC2 as the Dominant Intestinal Subset.
Abidi A; Laurent T; Bériou G; Bouchet-Delbos L; Fourgeux C; Louvet C; Triki-Marrakchi R; Poschmann J; Josien R; Martin J
Front Immunol; 2020; 11():255. PubMed ID: 32140157
[TBL] [Abstract][Full Text] [Related]
27. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.
Mielke LA; Groom JR; Rankin LC; Seillet C; Masson F; Putoczki T; Belz GT
J Immunol; 2013 Oct; 191(8):4383-91. PubMed ID: 24038093
[TBL] [Abstract][Full Text] [Related]
28. Group 3 Innate Lymphoid Cells: Communications Hubs of the Intestinal Immune System.
Withers DR; Hepworth MR
Front Immunol; 2017; 8():1298. PubMed ID: 29085366
[TBL] [Abstract][Full Text] [Related]
29. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.
Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L
Front Immunol; 2019; 10():910. PubMed ID: 31105707
[TBL] [Abstract][Full Text] [Related]
30. The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease.
Borger JG; Lau M; Hibbs ML
Front Immunol; 2019; 10():1597. PubMed ID: 31354734
[TBL] [Abstract][Full Text] [Related]
31. Dissecting human ILC heterogeneity: more than just three subsets.
Simoni Y; Newell EW
Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572
[TBL] [Abstract][Full Text] [Related]
32. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
Front Immunol; 2019; 10():217. PubMed ID: 30828332
[TBL] [Abstract][Full Text] [Related]
33. Mass cytometry reveals cladribine-induced resets among innate lymphoid cells in multiple sclerosis.
Aglas-Leitner FT; Juillard P; Juillard A; Byrne SN; Hawke S; Grau GE; Marsh-Wakefield F
Sci Rep; 2022 Nov; 12(1):20411. PubMed ID: 36437270
[TBL] [Abstract][Full Text] [Related]
34. Maintenance of Immune Homeostasis through ILC/T Cell Interactions.
von Burg N; Turchinovich G; Finke D
Front Immunol; 2015; 6():416. PubMed ID: 26322047
[TBL] [Abstract][Full Text] [Related]
35. Beyond NK cells: the expanding universe of innate lymphoid cells.
Cella M; Miller H; Song C
Front Immunol; 2014; 5():282. PubMed ID: 24982658
[TBL] [Abstract][Full Text] [Related]
36. NCR
Liu Y; Song Y; Lin D; Lei L; Mei Y; Jin Z; Gong H; Zhu Y; Hu B; Zhang Y; Zhao L; Teo HY; Qiu J; Jiang W; Dong C; Wu D; Huang Y; Liu H
EBioMedicine; 2019 Mar; 41():333-344. PubMed ID: 30827928
[TBL] [Abstract][Full Text] [Related]
37. Human innate lymphoid cells.
Montaldo E; Vacca P; Vitale C; Moretta F; Locatelli F; Mingari MC; Moretta L
Immunol Lett; 2016 Nov; 179():2-8. PubMed ID: 26844414
[TBL] [Abstract][Full Text] [Related]
38. Innate lymphoid cells in kidney diseases.
Wang R; Wang Y; Harris DCH; Cao Q
Kidney Int; 2021 May; 99(5):1077-1087. PubMed ID: 33387602
[TBL] [Abstract][Full Text] [Related]
39. Functional Differences between Human NKp44(-) and NKp44(+) RORC(+) Innate Lymphoid Cells.
Hoorweg K; Peters CP; Cornelissen F; Aparicio-Domingo P; Papazian N; Kazemier G; Mjösberg JM; Spits H; Cupedo T
Front Immunol; 2012; 3():72. PubMed ID: 22566953
[TBL] [Abstract][Full Text] [Related]
40. Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease.
Hazenberg MD; Haverkate NJE; van Lier YF; Spits H; Krabbendam L; Bemelman WA; Buskens CJ; Blom B; Shikhagaie MM
Blood Adv; 2019 Nov; 3(22):3650-3660. PubMed ID: 31751473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
